Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2012
11/28/2012CN102793838A Oral traditional Chinese medicament for treating warm-dryness cold
11/28/2012CN102793835A Chinese herbal medicine formula and preparation method thereof
11/28/2012CN102793820A Specific medicinal wine for treating scapulohumeral periarthritis
11/28/2012CN102793815A Medicament for treating soft tissue pain and tenosynovitis
11/28/2012CN102793809A Chinese herbal medicinal ointment for dredging meridians and removing toxin
11/28/2012CN102793787A Traditional Chinese medicine ointment for postoperative analgesia and wound healing promotion, and preparation method thereof
11/28/2012CN102793778A Cream for massaging and preparation method thereof
11/28/2012CN102793777A Groundsel garden burnet pain relieving powder
11/28/2012CN102793776A Externally applied fineleaf schizonepeta herb plaster for carbuncles and pyogenic infections
11/28/2012CN102793775A Garden burnet rhizoma corydalis paste
11/28/2012CN102793769A Oral traditional Chinese medicament for treating rheumatoid arthritis
11/28/2012CN102793768A Ginseng-ganodorma lucidum meridian-dredging capsule and production process thereof
11/28/2012CN102793765A Quick-acting defervescence oral liquid
11/28/2012CN102793753A Health care conditioning oil
11/28/2012CN102793744A Preparation method for blood-activation stasis-dissipation orifices-opening pain-relieving traditional Chinese medicine composition
11/28/2012CN102793729A Triptolide and chinese brake herb general flavone combined medicinal composition and preparation and application thereof
11/28/2012CN102793721A Application of human bone mesenchymal stem cells to preparation of medicament for treating ankylosing spondylitis
11/28/2012CN102793718A Pharmaceutical composition including aspirin salt and aluminium magnesium salt
11/28/2012CN102793713A Lincomycin hydrochloride-spectinomycin sulfate injection and preparation method thereof
11/28/2012CN102793712A Application of chrysin in preparation of medicaments for treating autoimmune and inflammatory diseases
11/28/2012CN102793700A Compound oil emulsion injection containing flumequine and preparation method thereof
11/28/2012CN102793692A Compounds for inflammation and immune-related uses
11/28/2012CN102793674A Triptolide solid lipid nanoparticle as well as preparation method and application thereof
11/28/2012CN102793673A Solid dispersion body of berberine-phospholipid complex and preparation method thereof
11/28/2012CN102793665A Flexible nanoliposomes with procyanidine and preparation method for flexible nanoliposomes
11/28/2012CN102793664A Sodium aescinate micro-emulsification injection and preparation method thereof
11/28/2012CN102793659A Aspirin suppository and preparation method thereof
11/28/2012CN102423393B Traditional Chinese medicinal composition for treating qi stagnation and blood stasis type primary dysmenorrhea
11/28/2012CN102302518B Cockroach extractive and prepared oral care composition as well as preparation method and applications
11/28/2012CN102293874B Multifunctional medicinal pillow and preparation method thereof
11/28/2012CN102293755B Two lyophilized powder injections of methylprednisolone sodium succinate and preparation methods thereof
11/28/2012CN102293754B Methylprednisolone sodium succinate freeze-dried powder injection and preparation method thereof
11/28/2012CN102274337B Chinese medicinal medicament for treating angioneurotic headache
11/28/2012CN102268070B Substrate metal prolease-9 polypeptide inhibitor 2 and application thereof
11/28/2012CN102268069B Substrate metal prolease-9 polypeptide inhibitor 4 and application thereof
11/28/2012CN102258588B Preparation method of peony general glycoside
11/28/2012CN102247315B OTC (Over the Counter) drug frozen sucker for treating symptoms of upper respiratory tract and oral cavity and preparation method thereof
11/28/2012CN102198126B Liniment for treating mouth and tooth diseases and applicator
11/28/2012CN102018717B Application of composition in preparing medicaments for preventing or treating colds and fevers
11/28/2012CN102002045B Pyrazolopyrimidinone derivatives as well as preparation method and application thereof
11/28/2012CN101918549B Improved humanized anti-human alpha9-integrin antibody
11/28/2012CN101917990B Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
11/28/2012CN101862456B Remedy
11/28/2012CN101855224B Equilibrative nucleoside transporter ENT1 inhibitors
11/28/2012CN101829291B Traditional Chinese medicine preparation for treating rheumatism and preparation method thereof
11/28/2012CN101708275B Chinese medicament for treating flu caused by influenza A(H1N1) and the like
11/28/2012CN101696183B (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof
11/28/2012CN101653546B Application of Chinese medicinal composition in preparation of medicament for treating rheumatic heart disease
11/28/2012CN101647792B Use of treprostinil to treat and prevent ischemic lesions
11/27/2012US8318951 Stem cell differentiating agents and uses therefor
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318769 Substituted sulfonamide compounds
11/27/2012US8318764 Macrocyclic inhibitors of JAK
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318744 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/27/2012US8318719 Inhibitors of Bruton's tyrosine kinase
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318640 Methods for selective targeting
11/27/2012US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
11/27/2012CA2672902C Formulations
11/27/2012CA2561944C Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
11/27/2012CA2467374C Indole-2-carboxamides as factor xa inhibitors
11/27/2012CA2451051C Siglec inhibitors
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/22/2012WO2012158789A2 Methods and compositions for inhibiting neddylation of proteins
11/22/2012WO2012158785A1 Azaindole derivatives as tyrosine kinase inhibitors
11/22/2012WO2012158672A2 Compounds for use in treatment of mucositis
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012157752A1 Pharmaceutical composition containing loxoprofen
11/22/2012WO2012157746A1 Therapeutic drug for autoimmune disease
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012157237A1 Osteogenesis promoter
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012WO2012156225A1 Use of a sulfurated compound for the treatment of hyper-homocysteinemia.
11/22/2012WO2012131656A3 Compounds for use as therapeutic agents affecting p53 expression and/or activity
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120295985 Methods for improving blood glucose control
11/22/2012US20120295980 Compounds and methods for delivery of prostacyclin analogs
11/22/2012US20120295978 Diclofenac gel
11/22/2012US20120295977 Organosulfur prodrugs for the prevention and treatment of infectious diseases
11/22/2012US20120295975 Methods of treating inflammatory conditions
11/22/2012US20120295968 Pharmaceutical Composition Comprising Cannabinoids
11/22/2012US20120295961 Modulation of hepatitis b virus (hbv) expression
11/22/2012US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/22/2012US20120295952 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
11/22/2012US20120295947 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
11/22/2012US20120295942 Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
11/22/2012US20120295940 Compositions for treating mastitis
11/22/2012US20120295934 New Hexahydrocyclopentapyrrolone, Hexahydropyrrolopyrrolone, Octahydropyrrolopyridinone and Octahydropyridinone Compounds
11/22/2012US20120295924 Thienopyrimidinedione derivatives as trpa1 modulators
11/22/2012US20120295922 Compounds For Use In Treatment Of Mucositis
11/22/2012US20120295919 Arylpiperazine opioid receptor antagonists
11/22/2012US20120295914 Combination of adrenergic receptor agonist alpha-1 or alpha-2, preferably brimonidine with fillers, preferably hyaluronic acid
11/22/2012US20120295912 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295902 Hetaryl-[1,8]naphthyridine derivatives
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295899 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 1272